Fundz

Immunis reported raising $20.4 Million in an initial SEC Form D filing, from an offering of $20 Million

PRIVATEJul 01, 2024

Amount Raised

$20.4 Million

$20.4 Million sold, per SEC Form D (first sale Jun 17, 2024)

Round Type

Venture

Laguna BeachBiotechnology

Quick answer

Immunis raised $20.4 Million in a funding round, dated June 17, 2024. Immunis is based in Laguna Beach, California, United States.

How much did Immunis raise?
Immunis raised $20.4 Million in a funding round on June 17, 2024.
What does Immunis do?
Immunis Inc. is a private, clinical-stage biotechnology company developing stem cell-derived secretome therapies to address age-related diseases and immune dysfunction.
Where is Immunis based and how big is it?
Immunis is based in Laguna Beach, California, United States.
Who are the decision-makers at Immunis?
Fundz holds 4 contacts at Immunis, including the Chief Business Officer and Head of Finance. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Immunis that raised within 45 days of this round, from Fundz verified event records.

  • IMUNON raised $10M on August 1, 2024.
  • NBOT Labs raised $1M (Seed) on August 1, 2024.
  • Healx raised $47M (Series C) on August 1, 2024.
  • Moonlight Therapeutics raised $2.4M on August 1, 2024.
  • Vital Care raised an undisclosed amount (Corporate Round) on August 1, 2024.
  • Flow Pharma raised $50K on July 31, 2024.

Who to call at Immunis, and when

A new round usually means Immunis is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Immunis raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Immunis, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Immunis. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Immunis

Location

1968 S. Coast Highway

Laguna Beach, California, United States

About

Immunis Inc. is a private, clinical-stage biotechnology company developing stem cell-derived secretome therapies to address age-related diseases and immune dysfunction. The secretome is the total set of factors secreted from a cell including proteins, lipids, growth factors, cytokines, and exosomes. A well-functioning immune system is necessary for our health and secretomes can refine immune cell responses, making them a promising therapeutic for autoimmune, neurodegenerative and age-related muscle wasting diseases (sarcopenia).

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Immunis raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

4 contacts
Verified contactsMark C., Chief Business Officer and Head of Fina… hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Immunis's next move

See what Strategic adds

Immunis raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.